Nektar Therapeutics
NKTR
NKTR
242 hedge funds and large institutions have $3.18B invested in Nektar Therapeutics in 2020 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 85 increasing their positions, 83 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
37% less call options, than puts
Call options by funds: $12.8M | Put options by funds: $20.2M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
58% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 57
Holders
242
Holding in Top 10
1
Calls
$12.8M
Puts
$20.2M
Top Buyers
| 1 | +$81.7M | |
| 2 | +$40.9M | |
| 3 | +$29.6M | |
| 4 |
M&T Bank
Buffalo,
New York
|
+$18.6M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$9.5M |
Top Sellers
| 1 | -$29.5M | |
| 2 | -$19.1M | |
| 3 | -$16M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$13.4M |
| 5 |
A
AustralianSuper
Melbourne,
Australia
|
-$9.7M |